{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:38:28Z","timestamp":1776407908730,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":4240,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jpain.2011.09.006","type":"journal-article","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T01:08:47Z","timestamp":1322096927000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Time Series Analysis of California\u2019s Prescription Monitoring Program: Impact on Prescribing and Multiple Provider Episodes"],"prefix":"10.1016","volume":"13","author":[{"given":"Aaron M.","family":"Gilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barth L.","family":"Wilsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Casamalhuapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Baxi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2011.09.006_bib1","series-title":"Principles of analgesic use in the treatment of acute pain and cancer pain. Sixth","year":"2008"},{"key":"10.1016\/j.jpain.2011.09.006_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2007.03.028","article-title":"Opioid dependence and addiction during opioid treatment of chronic pain","volume":"129","author":"Ballantyne","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2011.09.006_bib3","series-title":"Time series analysis: Forecasting and control. 3","author":"Box","year":"1994"},{"key":"10.1016\/j.jpain.2011.09.006_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1748-720X.2003.tb00058.x","article-title":"Maximizing the value of electronic prescription monitoring programs","volume":"31","author":"Brushwood","year":"2003","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.jpain.2011.09.006_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1475-6773.2006.00511.x","article-title":"Geographic variation in the prescription of Schedule II opioid analgesics amoung outpatients in the United States","volume":"41","author":"Curtis","year":"2006","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jpain.2011.09.006_bib6","unstructured":"Drug Enforcement Administration: Q & A State prescription drug monitoring programs. 2010. http:\/\/www.deadiversion.usdoj.gov\/faq\/rx_monitor.htm. Accessed November 14, 2011"},{"key":"10.1016\/j.jpain.2011.09.006_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1526-4637.2007.00370.x","article-title":"What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse\/addiction and\/or aberrant drug-related behaviors? A structured evidence-based review","volume":"9","author":"Fishbain","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2011.09.006_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1526-4637.2004.04049.x","article-title":"Regulating opioid prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain","volume":"5","author":"Fishman","year":"2004","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2011.09.006_bib9","series-title":"Bonica\u2019s Management of Pain","article-title":"Laws and policies involving pain management","author":"Gilson","year":"2010"},{"issue":"Suppl 2","key":"10.1016\/j.jpain.2011.09.006_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1526-4637.2009.00668.x","article-title":"The burden of the nonmedical use of prescription opioid analgesics","volume":"10","author":"Gilson","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2011.09.006_bib11","series-title":"Design and analysis of time-series experiments","author":"Glass","year":"2008"},{"key":"10.1016\/j.jpain.2011.09.006_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0885-3924(01)00410-9","article-title":"Pain management and prescription monitoring","volume":"23","author":"Joranson","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2011.09.006_bib13","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jama.283.13.1710","article-title":"Trends in medical use and abuse of opioid analgesics","volume":"283","author":"Joranson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2011.09.006_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1878","article-title":"Usefulness of prescription monitoring programs for surveillance: Analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006","volume":"19","author":"Katz","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpain.2011.09.006_bib15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4065\/79.8.1031","article-title":"Taking the physician out of \u201cphysician shopping\u201d: A case series of clinical problems associated with internet purchases of medication","volume":"79","author":"Lineberry","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpain.2011.09.006_bib16","series-title":"Interrupted time series analysis","author":"McDowall","year":"1980"},{"key":"10.1016\/j.jpain.2011.09.006_bib17","unstructured":"Medical Board of California: Clarification of Senate Bill 151, 2004"},{"key":"10.1016\/j.jpain.2011.09.006_bib18","unstructured":"Office of National Drug Control Policy: National drug control strategy. NCJ 203722. The White House, 2004"},{"key":"10.1016\/j.jpain.2011.09.006_bib19","series-title":"Pain & Policy Studies Group: Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation","year":"2008"},{"key":"10.1016\/j.jpain.2011.09.006_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pds.1681","article-title":"Impact of prescription monitoring program on doctor-shopping for high dosage buprenorphine","volume":"18","author":"Pradel","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpain.2011.09.006_bib21","series-title":"RED BOOK Ambulatory Care Drug Database Coding System","year":"2006"},{"key":"10.1016\/j.jpain.2011.09.006_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/clpt.1991.116","article-title":"Effect of the requirement for triplicate prescriptions for benzodiazepines in New York State","volume":"50","author":"Reidenberg","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpain.2011.09.006_bib23","first-page":"41","article-title":"Prescription opioid usage and abuse relationships: An evaluation of state prescription drug monitoring program efficacy","volume":"3","author":"Reisman","year":"2009","journal-title":"Subst Abuse"},{"key":"10.1016\/j.jpain.2011.09.006_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2190\/8FR4-QYY1-7MYG-2AGJ","article-title":"A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a medicaid population","volume":"34","author":"Ross-Degnan","year":"2004","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.jpain.2011.09.006_bib25","first-page":"108","article-title":"Effect of a triplicate prescription law on prescribing of Schedule II drugs","volume":"41","author":"Sigler","year":"1984","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.jpain.2011.09.006_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0149-2918(04)90030-6","article-title":"A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in Medicaid patients with chronic psychiatric and neurologic disorders","volume":"26","author":"Simoni-Wastila","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jpain.2011.09.006_bib27","unstructured":"United States General Accounting Office: Prescription drugs: State monitoring programs provide useful tool to reduce diversion. Washington, DC: United States General Accounting Office, GAO-02-634, 2002"},{"key":"10.1016\/j.jpain.2011.09.006_bib28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1592\/phco.21.15.1159.33898","article-title":"Effect of triplicate prescription policy on benzodiazepine administration in nursing home residents","volume":"21","author":"Van Haaren","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpain.2011.09.006_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/intqhc\/mzg064","article-title":"Effects of state surveillance on new post-hospitalization benzodiazepine use","volume":"15","author":"Wagner","year":"2003","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jpain.2011.09.006_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J088v04n03_02","article-title":"The influence of multiple copy prescription programs on analgesic utilization","volume":"4","author":"Wastila","year":"1996","journal-title":"J Pharm Care Pain Symptom Control"},{"key":"10.1016\/j.jpain.2011.09.006_bib31","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.1991.03470170080028","article-title":"Consequences of the 1989 New York State Triplicate Benzodiazepine Prescription Regulations","volume":"266","author":"Weintraub","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2011.09.006_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.drugalcdep.2010.05.007","article-title":"Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics","volume":"112","author":"Wilsey","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2011.09.006_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/106002809202600417","article-title":"Impact of triplicate prescription program on psychotropic prescribing patterns in long-term care facilities","volume":"26","author":"Zullich","year":"1992","journal-title":"Ann Pharmacother"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590011007887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590011007887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:51:57Z","timestamp":1761508317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590011007887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1526590011007887"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2011.09.006","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time Series Analysis of California\u2019s Prescription Monitoring Program: Impact on Prescribing and Multiple Provider Episodes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2011.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}